Effects of Canagliflozin on Cardiovascular, Renal, and Safety Outcomes in Participants With Type 2 Diabetes and Chronic Kidney Disease According to History of Heart Failure: Results From the CREDENCE Trial

Publication date: Available online 22 December 2020Source: American Heart JournalAuthor(s): Ashish Sarraju, JingWei Li, Christopher P. Cannon, Tara I. Chang, Rajiv Agarwal, George Bakris, David M. Charytan, Dick de Zeeuw, Tom Greene, Hiddo J.L. Heerspink, Adeera Levin, Bruce Neal, Carol Pollock, David C. Wheeler, Yshai Yavin, Hong Zhang, Bernard Zinman, Vlado Perkovic, Meg Jardine, Kenneth W. Mahaffey
Source: American Heart Journal - Category: Cardiology Source Type: research